Correlation Between China Construction and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both China Construction and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Construction and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Construction Bank and Emergent Biosolutions, you can compare the effects of market volatilities on China Construction and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Construction with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Construction and Emergent Biosolutions.
Diversification Opportunities for China Construction and Emergent Biosolutions
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between China and Emergent is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding China Construction Bank and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and China Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Construction Bank are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of China Construction i.e., China Construction and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between China Construction and Emergent Biosolutions
Assuming the 90 days horizon China Construction Bank is expected to generate 0.64 times more return on investment than Emergent Biosolutions. However, China Construction Bank is 1.57 times less risky than Emergent Biosolutions. It trades about 0.11 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.06 per unit of risk. If you would invest 82.00 in China Construction Bank on May 4, 2025 and sell it today you would earn a total of 22.00 from holding China Construction Bank or generate 26.83% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
China Construction Bank vs. Emergent Biosolutions
Performance |
Timeline |
China Construction Bank |
Emergent Biosolutions |
China Construction and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with China Construction and Emergent Biosolutions
The main advantage of trading using opposite China Construction and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Construction position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.China Construction vs. Svenska Handelsbanken PK | China Construction vs. ANZ Group Holdings | China Construction vs. Westpac Banking | China Construction vs. National Australia Bank |
Emergent Biosolutions vs. Elanco Animal Health | Emergent Biosolutions vs. SIGA Technologies | Emergent Biosolutions vs. Esperion Therapeutics | Emergent Biosolutions vs. Vir Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |